{"id":"NCT00630331","sponsor":"Novartis Vaccines","briefTitle":"Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects","officialTitle":"A Phase III, Randomized, Observer-Blind, Placebo-Controlled, Multicenter Study to Assess Clinical Efficacy of a Cell-Derived Subunit Influenza Vaccine and an Egg-Derived Subunit Influenza Vaccine in the 2007-2008 Influenza Season in Healthy Adult Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-10","primaryCompletion":"2008-07","completion":"2008-07","firstPosted":"2008-03-07","resultsPosted":"2013-01-16","lastUpdate":"2024-05-24"},"enrollment":11404,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Cell culture-derived influenza vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Egg-derived influenza virus vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"CCI","type":"EXPERIMENTAL"},{"label":"IVV","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The present study will evaluate clinical efficacy, safety, tolerability and immunogenicity of both Novartis Vaccines' cell-derived influenza vaccine and egg-derived influenza vaccine in healthy adults 18 to 49 years of age.","primaryOutcome":{"measure":"Number of Subjects With Culture-Confirmed Influenza Illness Caused by Vaccine-like Strains","timeFrame":"6 Months","effectByArm":[{"arm":"CCI Vaccine","deltaMin":7,"sd":null},{"arm":"IVV Vaccine","deltaMin":9,"sd":null},{"arm":"Placebo","deltaMin":44,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG002","p":"0.999"},{"comp":"OG000 vs OG002","p":"0.394"},{"comp":"OG001 vs OG002","p":"0.004"},{"comp":"OG001 vs OG002","p":"0.002"},{"comp":"OG001 vs OG002","p":"0.992"},{"comp":"OG001 vs OG002","p":"0.400"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":56,"countries":["United States","Finland","Poland"]},"refs":{"pmids":["20868284"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":42,"n":3813},"commonTop":["Injection Site Pain","Headache","Injection Site Erythema","Fatigue","Myalgia"]}}